ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0783

Role of Glutamine Metabolism in Rheumatoid Arthritis Fibroblast-Like Synoviocyte Aggressive Phenotype

Alyssa Torres1, Brian Pedersen1, Gary Firestein2, Elsa Sanchez-Lopez1 and Monica Guma3, 1University of California San Diego, La Jolla, 2University of California, San Diego, La Jolla, CA, 3Division of Rheumatology, University of California San Diego, Department of Medicine, Autonomous University of Barcelona, La Jolla, CA

Meeting: ACR Convergence 2020

Keywords: Fibroblasts, Synovial, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 7, 2020

Title: RA – Etiology & Pathogenesis Poster

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Fibroblast-like synoviocyte (FLS) activation is a key component of rheumatoid arthritis (RA) inflamed synovium.  Their aggressive phenotype in RA contributes to initiation and perpetuation of destructive joint inflammation. Understanding changes in RA FLS metabolism is becoming a new focus of research in RA. We previously showed that the glutaminase gene, which encodes for the enzyme that generates glutamate from glutamine, is highly epigenetically regulated in RA FLS compared to osteoarthritis (OA) FLS. Here, we determined the importance of glutamine (gln) as an alternate carbon source to glucose for FLS and whether or not interference of this pathway can decrease the aggressive phenotype of FLS in RA.

Methods: Uptake of glutamine was determined by Glutamine/Glutamate-Glo kit by Promega. Dependence of glutamine by RA FLS was determined by functional assays, including invasion (matrigel assay), proliferation assays (EdU assay), and a migration assay (scratch assay), that were conducted using DMEM without glucose supplemented with dialyzed fetal bovine serum. We then used increasing amounts of glutamine before and after PDGF stimulation in the presence or absence of glucose. RA FLS were also incubated with CB-839 (300nM), a glutaminase inhibitor.

Results: Glutamine/glutamate luminescence test displayed significant glutamine uptake in FLS starved of glucose after PDGF stimulation (3938±10425 vs 1165±371.8, p< 0.0001). Functional assays revealed that 6mM glutamine (FLS cultured in a media without glucose) is sufficient as an alternate source of energy to 6mM glucose (FLS cultured in media without gln) in proliferation (6mM gln 0.3±0.07 vs 6mM glucose 0.37±0.21; ns) and invasion (6mM gln 21.47±1.34 vs 6mM glucose 20.91±1.3; ns). In addition, the use of glutamine allows for an increase of invasion (0mM gln 12.87±3.316 vs 6mM 18.83±3.236; p< 0.002), proliferation (0mM gln 8.752±4.7 vs. 6mM gln 40.55±14.07; p< 0.02), and migration (0mM gln 219.8±49.88 vs 6mM gln 186.4±45.90; p=0.0002) in the absence of glucose. Of interest, OA FLS do not migrate more on 6mM glutamine compared to 0mM glutamine (0mM gln 216.1±46.35 vs 6mM gln 219.4±58.64; ns). Experiments with CB-839 showed significant decrease in invasion (vehicle 23.11±3.161 vs CB-839 14.46±2.036 p< 0.0001) and proliferation (vehicle 0.2548±0.03589 vs CB-839 0.1278±0.02861 p< 0.0001) of RA FLS under glucose depletion with varying amounts of glutamine compared with vehicle control.

Conclusion: RA FLS are able to utilize glutamine as an alternative carbon source in the absence of glucose, which mimics the starvation conditions within the joint. Glutaminase could potentially be a good target to reduce the aggressive phenotype of FLS in RA.


Disclosure: A. Torres, None; B. Pedersen, None; G. Firestein, Eli Lilly, 2; E. Sanchez-Lopez, None; M. Guma, None.

To cite this abstract in AMA style:

Torres A, Pedersen B, Firestein G, Sanchez-Lopez E, Guma M. Role of Glutamine Metabolism in Rheumatoid Arthritis Fibroblast-Like Synoviocyte Aggressive Phenotype [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/role-of-glutamine-metabolism-in-rheumatoid-arthritis-fibroblast-like-synoviocyte-aggressive-phenotype/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/role-of-glutamine-metabolism-in-rheumatoid-arthritis-fibroblast-like-synoviocyte-aggressive-phenotype/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology